ENZ
Enzo Biochem, Inc.
Delisted
ENZ was delisted on the 17th of April, 2025.
39 hedge funds and large institutions have $23.1M invested in Enzo Biochem, Inc. in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 9 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
33% less capital invested
Capital invested by funds: $34.7M → $23.1M (-$11.5M)
64% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 11
Holders
39
Holding in Top 10
1
Calls
$165K
Puts
$34K
Top Buyers
| 1 | +$567K | |
| 2 | +$87.5K | |
| 3 | +$11.2K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$7.76K |
| 5 |
C
Covestor
London,
United Kingdom
|
+$6K |
Top Sellers
| 1 | -$1.81M | |
| 2 | -$1.25M | |
| 3 | -$594K | |
| 4 |
Renaissance Technologies
New York
|
-$208K |
| 5 |
FLC
Fifth Lane Capital
Austin,
Texas
|
-$156K |